Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
JAPSC Mohamed Supplement 4

Riyadh Qasim

Watch time: 2s
JAPSC Mohamed Supplement 2

Riyadh Qasim

Watch time: 2s
JAPSC Mohamed Supplement 2

Riyadh Qasim

Watch time: 2s
JAPSC Mohamed Supplement 1

Riyadh Qasim

Watch time: 2s

Perry Elliott

Watch time: 18m 27s (2 videos)

Broadcast

Heart Failure

Intervention
Infarct Size, Microvascular Obstruction and Outcomes in STEMI: An Expert…

Nadia Sutton, Suzanne de Waha, Jay Traverse , et al

Watch time: 45m 11s

Broadcast

Heart Failure

MI/ACS
Valsartan Sacubitril: Has our PARADIGM shifted?

Giuseppe Rosano, Richard Henry P Tiongco, Rungroj Krittayaphong , et al

Watch time: 53m 45s
View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen

Watch time: 33m 19s
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF

Muthiah Vaduganathan

Watch time: 5m 1s
ESC 22: PERSPECTIVE: Sacubitril/Valsartan & Cognitive Function in HFmrEF &

John JV McMurray

Watch time: 5m 51s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ESC 22: The EMMY Trial: Empagliflozin in Pts with Acute MI

Harald Sourij

Watch time: 2m 55s
ESC 22: 3 Trials That Will Change Your Practice With Dr Alasnag

Mirvat Alasnag

Watch time: 6m 50s
ESC 22 Late-breaker Discussion: The ADVOR Trial

Harriette Van Spall, Wilfried Mullens

Watch time: 11m 5s
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad

Watch time: 4m 44s
ESC 22: 3 Trials That Will Change Your Practice With Dr Purvi Parwani

Purvi Parwani

Watch time: 9m 51s